Synulox Lactating Cow is specially formulated for the treatment of bovine mastitis. It has a notably broad spectrum of bactericidal activity against the bacteria commonly isolated from the bovine udder.

The prednisolone in Synulox Lactating Cow has an anti-inflammatory action which helps to reduce the potentially destructive swelling and inflammation associated with mastitis, without affecting the white cell response to infection.

In vitro Synulox is active against a wide range of clinically important bacteria, including the following organisms, which are commonly associated with bovine mastitis:

Staphylococci (including beta-lactamase-producing strains),

Streptococci (including S. agalactiae, S. dysgalactiae and S. uberis),

A. pyogenes and other minor members of the Corynebacteria spp.

Escherichia coli (including beta-lactamase producing strains). In addition, it is active in vitro against many less common udder pathogens including: Bacillus cereus, Bacteroides (including β-lactamase producing strains) Campylobacter spp., Klebsiellae and Pasteurellae.

Clinically, Synulox Lactating Cow has been shown to be an effective routine treatment for mastitis in lactating cows. Cases responding successfully to treatment include infections with the following major pathogens:

Staphylococci (including β-lactamase producing strains),

Streptococci (including S. agalactiae, S. dysgalactiae, and S. uberis),

Escherichia coli (including β-lactamase-producing strains).